Literature DB >> 26339458

Role of neovibsanin scaffold in preservation of spatial cognitive functions of rats with chronic epilepsy.

Li-Quan Dong1, Li-Li Yan2, Xu-Dong Pan1, Jin-Hua Hu3, Jun-Wei Zhang4.   

Abstract

The effect of neovibsanin scaffold (NS) on the spatial cognitive functions of rats with lobal cerebrovascular hypoperfusion was investigated. Rats were divided into long-term memory (LTM) and short-term memory (STM) groups with 15 rats in each group. The groups were subdivided into 3 groups: control group comprised of 5 rats without surgery, untreated group of 5 rats left without treatment after 2OV, and NS treatment group with 5 rats receiving 5 mg/kg daily for 12 weeks of 2VO operation. NS-treatment caused a marked decrease in the escape latency time and total distance travelled in the treatment group compared to untreated group which was evident from the working memory test. The animals of treatment group also showed significant improvement over that of untreated group in maze test performance. Furthermore, NS treatment also resulted in significant improvement in the probe memory test performance in treatment group compared to untreated group. These findings suggest that NS exhibits therapeutic effect on the spatial cognitive preservation in rats with chronic epilepsy.

Entities:  

Keywords:  Chronic epilepsy; Morris water maze; cognitive; escape latency; working memory test

Mesh:

Substances:

Year:  2015        PMID: 26339458      PMCID: PMC4555786     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.

Authors:  P Giannakopoulos; F R Herrmann; T Bussière; C Bouras; E Kövari; D P Perl; J H Morrison; G Gold; P R Hof
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

Review 2.  NMDA receptors, place cells and hippocampal spatial memory.

Authors:  Kazu Nakazawa; Thomas J McHugh; Matthew A Wilson; Susumu Tonegawa
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

3.  Syntheses of structurally-simplified and fluorescently-labeled neovibsanin derivatives and analysis of their neurite outgrowth activity in PC12 cells.

Authors:  Hiroshi Imagawa; Hayato Saijo; Hitomi Yamaguchi; Ken Maekawa; Takahiro Kurisaki; Hirofumi Yamamoto; Mugio Nishizawa; Masataka Oda; Michiko Kabura; Masahiro Nagahama; Jun Sakurai; Miwa Kubo; Megumi Nakai; Kosho Makino; Mitsuko Ogata; Hironobu Takahashi; Yoshiyasu Fukuyama
Journal:  Bioorg Med Chem Lett       Date:  2012-01-11       Impact factor: 2.823

4.  Altered expression of MAP-2, GAP-43, and synaptophysin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment.

Authors:  Han-Xing Liu; Jun-Jian Zhang; Ping Zheng; Yi Zhang
Journal:  Brain Res Mol Brain Res       Date:  2005-09-13

5.  Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions.

Authors:  Mark E Obrenovich; Mark A Smith; Sandra L Siedlak; Shu G Chen; Jack C de la Torre; George Perry; Gjumrakch Aliev
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.911

Review 6.  Molecular genetics of familial Alzheimer disease.

Authors:  B S Shastry
Journal:  Am J Med Sci       Date:  1998-04       Impact factor: 2.378

7.  The decline of working memory in Alzheimer's disease. A longitudinal study.

Authors:  A D Baddeley; S Bressi; S Della Sala; R Logie; H Spinnler
Journal:  Brain       Date:  1991-12       Impact factor: 13.501

8.  Developments of a water-maze procedure for studying spatial learning in the rat.

Authors:  R Morris
Journal:  J Neurosci Methods       Date:  1984-05       Impact factor: 2.390

9.  Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.

Authors:  Clive Holmes; Delphine Boche; David Wilkinson; Ghasem Yadegarfar; Vivienne Hopkins; Anthony Bayer; Roy W Jones; Roger Bullock; Seth Love; James W Neal; Elina Zotova; James A R Nicoll
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

10.  Frequent amyloid deposition without significant cognitive impairment among the elderly.

Authors:  Howard Jay Aizenstein; Robert D Nebes; Judith A Saxton; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Scott K Ziolko; Jeffrey A James; Beth E Snitz; Patricia R Houck; Wenzhu Bi; Ann D Cohen; Brian J Lopresti; Steven T DeKosky; Edythe M Halligan; William E Klunk
Journal:  Arch Neurol       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.